Twenty-four weeks of interferon alpha-2b in combination with ribavirin for Japanese hepatitis C patients: sufficient treatment period for patients with genotype 2 but not for patients with genotype 1.

Source:http://linkedlifedata.com/resource/pubmed/id/16761995

Download in:

View as

Triples

General Info

PMID
16761995